These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10708958)

  • 1. TGF-betas and TGF-beta receptors in atherosclerosis.
    McCaffrey TA
    Cytokine Growth Factor Rev; 2000; 11(1-2):103-14. PubMed ID: 10708958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.
    McCaffrey TA; Consigli S; Du B; Falcone DJ; Sanborn TA; Spokojny AM; Bush HL
    J Clin Invest; 1995 Dec; 96(6):2667-75. PubMed ID: 8675633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance.
    McCaffrey TA; Du B; Fu C; Bray PJ; Sanborn TA; Deutsch E; Tarazona N; Shaknovitch A; Newman G; Patterson C; Bush HL
    J Mol Cell Cardiol; 1999 Sep; 31(9):1627-42. PubMed ID: 10471347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-induced downregulation of receptors for TGF-beta in human osteoblast-like cells from adult donors.
    Gebken J; Feydt A; Brinckmann J; Notbohm H; Müller PK; Bätge B
    J Endocrinol; 1999 Jun; 161(3):503-10. PubMed ID: 10334821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development.
    Bobik A; Agrotis A; Kanellakis P; Dilley R; Krushinsky A; Smirnov V; Tararak E; Condron M; Kostolias G
    Circulation; 1999 Jun; 99(22):2883-91. PubMed ID: 10359732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
    Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
    Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth.
    Smith JD; Bryant SR; Couper LL; Vary CP; Gotwals PJ; Koteliansky VE; Lindner V
    Circ Res; 1999 May; 84(10):1212-22. PubMed ID: 10347096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.
    De Groot CJ; Montagne L; Barten AD; Sminia P; Van Der Valk P
    J Neuropathol Exp Neurol; 1999 Feb; 58(2):174-87. PubMed ID: 10029100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
    Wikström P; Lindh G; Bergh A; Damber JE
    Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury.
    Ward MR; Agrotis A; Kanellakis P; Dilley R; Jennings G; Bobik A
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2461-70. PubMed ID: 9409216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of type I and type II transforming growth factor-beta receptors in central nervous tissues: changes induced by focal cerebral ischemia.
    Vivien D; Bernaudin M; Buisson A; Divoux D; MacKenzie ET; Nouvelot A
    J Neurochem; 1998 Jun; 70(6):2296-304. PubMed ID: 9603194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factors beta1, beta2 and beta3 and their receptors are differentially expressed in human peritoneal fibroblasts in response to hypoxia.
    Saed GM; Collins KL; Diamond MP
    Am J Reprod Immunol; 2002 Dec; 48(6):387-93. PubMed ID: 12607775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells.
    Waiser J; Dell K; Böhler T; Dogu E; Gaedeke J; Budde K; Neumayer HH
    Nephrol Dial Transplant; 2002 Sep; 17(9):1568-77. PubMed ID: 12198207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of transforming growth factor (TGF)-beta Type I and TGF-beta type II receptors in the TGF-beta1-regulated gene expression in pituitary prolactin-secreting lactotropes.
    Sarkar DK; Pastorcic M; De A; Engel M; Moses H; Ghasemzadeh MB
    Endocrinology; 1998 Aug; 139(8):3620-8. PubMed ID: 9681516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis.
    Oh SP; Seki T; Goss KA; Imamura T; Yi Y; Donahoe PK; Li L; Miyazono K; ten Dijke P; Kim S; Li E
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2626-31. PubMed ID: 10716993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and action of transforming growth factor-beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol.
    Kassem M; Kveiborg M; Eriksen EF
    Eur J Clin Invest; 2000 May; 30(5):429-37. PubMed ID: 10809903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
    MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
    Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of tranilast on expression of transforming growth factor-beta isoforms and receptors in injured arteries.
    Ward MR; Sasahara T; Agrotis A; Dilley RJ; Jennings GL; Bobik A
    Atherosclerosis; 1998 Apr; 137(2):267-75. PubMed ID: 9622270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pulmonary acinar aplasia: reduction of transforming growth factor-beta ligands and receptors.
    Chen MF; Gray KD; Prentice MA; Mariano JM; Jakowlew SB
    Pediatr Res; 1999 Jul; 46(1):61-70. PubMed ID: 10400136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.